Generic Orap
Description: Orap (Pimozide) is an antipsychotic agent used to manage the symptoms of schizophrenia and Tourette's syndrome. Orap (Pimozide) may also be used to treat other conditions as determined by your doctor.
What is Generic Orap?
Generic Orap, like all generics, is the name given to the
prescription Pimozide medication manufactured by any company other than the
original inventor of Orap. The only true difference between brand name Orap
and generic Orap is that generic Orap is always less expensive.
Related products: Antalon, Opiran, Oralep Forte, Pimozida, Pimozidum, Pirium, Pimozide (generic name).
Orap manufactured by Aca Müller/Adag Pharma and Emra-Med is at Goldpharma Medication | Strength | Quantity | Price | Goldpharma | Orap | 1 mg | 75 tablets | $38.02 | Order | Orap Forte | 4 mg | 20 tablets | $33.32 | Order | Orap Forte | 4 mg | 50 tablets | $47.68 | Order |
Buy Generic Orap - No Prior Prescription Needed*
How To Buy Generic Orap Online
Buy discount generic Orap (Pimozide) online by clicking on one of the low
prices shown. You'll be sent to our secure shopping cart where you can safely
complete your transaction.
Orap - Health Bulletin
Swimmer's EarMelissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology. Read entire article...
Please verify your local import regulations; the ability for a pharmacy to
offer a medication without a prescription does not negate any local requirement
you may have.
NOTICE: By using this site, you agree to verify and comply with your
country's rules and regulations should you undertake to purchase from any of
the listed pharmacies.
|